Is a complete FRA/APE research report available?

No complete published report is available for fra/APE (FRA/APE) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/APE (FRA/APE)

Frankfurt Stock Exchange: FRA/APE · EUR

€0.04

-0.00 (-1.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/APE analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	5.3M
Revenue (ttm)	118.4K
Net income (ttm)	-7.5M
EPS (ttm)	-€0.07

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 118.4K
Net income (ttm): -7.5M
EPS (ttm): -€0.07
Market cap: 5.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

All FRA/APE indicators

Market & fundamental data

Available fields

147

Groups with data

Currency

CHF

Showing 147 of 147 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	DE
Employees	3
Employees Change	-21%
Employees Change Percent	-91.3
Enterprise value	EUR 4.4M
Exchange	Frankfurt Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-07-31
Market cap	EUR 5.3M
Price	EUR 0.04
Price currency	EUR
Rev Per Employee	39,464.67x
Sic	2834
Symbol	fra/APE
Website	https://www.addextherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-143.04%
EV/Sales	37.29x
FCF yield	-47.57%
P/B ratio	1.48x
P/S ratio	44.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -478,152
Net Income	EUR -7.5M
Pretax Margin	-6,467.3%
Profit Per Employee	EUR -2.5M
ROA	-23.59
Roa5y	-30.59
ROCE	-76
ROE	-122.3
Roe5y	-92.85
ROIC	-28.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	15.73%
Revenue Growth	-55.52x
Revenue Growth Q	-89.18x
Revenue Growth3 Y	-59.94x
Revenue Growth5 Y	-50.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.02
Assets	EUR 5.1M
Cash	EUR 1M
Current Assets	EUR 1.3M
Current Liabilities	EUR 1.3M
Debt	EUR 110,579
Debt Equity	EUR 0.03
Debt FCF	EUR -0.04
Equity	EUR 3.6M
Interest Coverage	-950.2
Liabilities	EUR 1.6M
Long Term Assets	EUR 3.9M
Long Term Liabilities	EUR 282,790
Net Cash	EUR 900,564
Net Cash By Market Cap	EUR 17.1
Net Cash Growth	-70.1%
Net Debt Equity	EUR -0.25
Tangible Book Value	EUR 3.6M
Tangible Book Value Per Share	EUR 0.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.97
Net Working Capital	EUR -962,831
Quick ratio	0.79
Working Capital	EUR -35,206
Working Capital Turnover	EUR 0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	15.71%
200-day SMA	0.05
50-day SMA	0.04
50-day SMA vs 200-day SMA	50under200
All Time High	0.08
All Time High Change	-50%
All Time High Date	2025-07-08
All Time Low	0
All Time Low Change	1,250%
All Time Low Date	2025-05-06
ATR	0
Ch YTD	-24.3
High	0.04
High52	0.08
High52 Date	2025-07-29
High52ch	-48.39%
Low	0.04
Low52	0.03
Low52 Date	2025-08-22
Low52ch	29.03%
Ma50ch	-2.64%
Price vs 200-day SMA	-11.96%
RSI	49.95
RSI Monthly	41.11
RSI Weekly	47.08
Sharpe ratio	1.51x
Sortino ratio	2.93
Total Return	-14.34%
Tr YTD	-24.3
Tr1m	9.46%
Tr1w	-1.22%
Tr3m	1.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -2.9M
Operating margin	-2,455

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,064,535%
Net Borrowing	-7,571.2
Shares Insiders	18.65%
Shares Institutions	1.09%
Shares Qo Q	0.55%
Shares Yo Y	14.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -2.6M
Adjusted OCF	-2,578,796.7
Average Volume	19.4x
Bv Per Share	0.03
Ch1m	9.46
Ch1w	-1.22
Ch1y	15.71
Ch3m	1.25
Ch6m	-24.3
Change	-1.23%
Change From Open	0
Close	0.04
Days Gap	-1.23
Depreciation Amortization	-1,701.3
Earnings Date	2026-08-24
EBIT	EUR -2.9M
EBITDA	EUR -2.9M
EPS	EUR -0.07
F Score	1
FCF	EUR -2.5M
FCF EV Yield	-57.27x
Financing CF	1,244,852
Fiscal Year End	December
Founded	2,002
Investing CF	-735,999
Is Primary Listing	0
Last Earnings Date	2026-06-15
Last Report Date	2026-03-31
Ma150	0.05
Ma150ch	-10.6%
Ma20	0.04
Ma20ch	2.02%
Net CF	-2,043,939
Next Earnings Date	2026-08-24
Open	0.04
Ppne	108,678.4
Price Date	2026-07-30
Ptbv Ratio	1.48
Relative Volume	20x
Revenue	118,394x
SBC By Revenue	62.84x
Share Based Comp	74,401
Tr6m	-24.3%
Z Score	-105.9

FRA/APE (FRA/APE)

Coverage state: Market snapshot only — no published research

Generate the first FRA/APE analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/APE

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All FRA/APE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/APE

Frequently asked questions